Page last updated: 2024-08-17

lysine and exenatide

lysine has been researched along with exenatide in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Al-Sabah, S; Donnelly, D1
Chae, SY; Choi, YG; Jung, SY; Lee, DS; Lee, KC; Son, S1
Benoist, C; Gaglia, J; Kohler, RH; Kulkarni, RN; Li, L; Liew, CW; Mathis, D; Reiner, T; Thurber, G; Upadhyay, R; Vinegoni, C; Weissleder, R1
Chae, SY; Kim, K; Lee, KC; Lim, SM; Na, DH; Park, EJ; Son, S1

Other Studies

4 other study(ies) available for lysine and exenatide

ArticleYear
The positive charge at Lys-288 of the glucagon-like peptide-1 (GLP-1) receptor is important for binding the N-terminus of peptide agonists.
    FEBS letters, 2003, Oct-23, Volume: 553, Issue:3

    Topics: Amino Acid Sequence; Amino Acid Substitution; Binding, Competitive; Cells, Cultured; Cyclic AMP; Exenatide; Glucagon-Like Peptide-1 Receptor; Humans; Inhibitory Concentration 50; Kidney; Ligands; Lysine; Molecular Sequence Data; Peptide Fragments; Peptides; Radioligand Assay; Receptors, Glucagon; Recombinant Proteins; Sequence Homology, Amino Acid; Transfection; Venoms

2003
The fatty acid conjugated exendin-4 analogs for type 2 antidiabetic therapeutics.
    Journal of controlled release : official journal of the Controlled Release Society, 2010, May-21, Volume: 144, Issue:1

    Topics: Animals; Antigens; Diabetes Mellitus; Diabetes Mellitus, Type 2; Exenatide; Fatty Acids; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Half-Life; Hypoglycemic Agents; Lysine; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Palmitic Acid; Peptides; Rats; Rats, Sprague-Dawley; Receptors, Glucagon; Venoms

2010
Accurate measurement of pancreatic islet beta-cell mass using a second-generation fluorescent exendin-4 analog.
    Proceedings of the National Academy of Sciences of the United States of America, 2011, Aug-02, Volume: 108, Issue:31

    Topics: Amino Acid Sequence; Animals; Binding Sites; Cell Line, Tumor; Diabetes Mellitus, Type 1; Exenatide; Fluorescent Dyes; Glucagon-Like Peptide-1 Receptor; Green Fluorescent Proteins; HEK293 Cells; Humans; Insulin-Secreting Cells; Laparoscopy; Lysine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Confocal; Microscopy, Fluorescence; Molecular Sequence Data; NIH 3T3 Cells; Pancreas; Peptides; Receptors, Glucagon; Streptozocin; Venoms

2011
Mono-lithocholated exendin-4-loaded glycol chitosan nanoparticles with prolonged antidiabetic effects.
    International journal of pharmaceutics, 2015, Nov-10, Volume: 495, Issue:1

    Topics: Animals; Chitosan; Diabetes Mellitus, Type 2; Drug Carriers; Drug Liberation; Exenatide; Hypoglycemic Agents; Lithocholic Acid; Lysine; Mice; Nanoparticles; Particle Size; Peptides; Succinimides; Venoms

2015